Document Detail

Efficacy of transdermal nitroglycerin patches evaluated by dipyridamole-induced myocardial ischemia in patients with coronary artery disease. Comparison between continuous and intermittent schedule.
MedLine Citation:
PMID:  12766388     Owner:  NLM     Status:  MEDLINE    
Nitrate tolerance remains a problem despite an enormous number of studies on this phenomenon. The aim of the present study was to compare the efficacy of nitroglycerin transdermal patches intermittently or continuously administered to patients with myocardial ischemia evaluated by the echocardiography dipyridamole stress test. We prospectively studied 34 coronary patients with stable myocardial ischemia. A double-blind, randomized, crossover study technique was used. After a run-in period (1 week) they underwent a dipyridamole stress test to evaluate nitrate responsiveness and then were randomized to 1 week of transdermal nitroglycerine 20 mg/24 h (two patches of 10 mg/24) administered either intermittently or continuously for 1 week. During the following week all patients were given placebo. In the final week, therapy was crossed over the alternate regimen. No significant changes in heart rate, systolic and diastolic blood pressure and rate-pressure product were observed at basal conditions and at peak of dipyridamole infusion among patients after placebo run-in period, after acute, 1 week of intermittent and 1 week of continuous nitroglycerine administration. At peak of dipyridamole infusion after acute administration of nitrate we observed a significant decrease in wall motion score index with respect to placebo. This pattern was similar during intermittent, but not continuous, patch therapy (p < 0.001). Our results suggest that transdermal nitroglycerin patches are an effective anti-ischemic medication, in reducing transient myocardial ischemia induced by dipyridamole. This anti-ischemic effect is lost when an overnight nitrate free dose interval is not used. Moreover the dipyridamole echocardiographic stress test, besides evaluating myocardial ischemia-induced wall motion abnormalities, is adequate to assess both the efficacy and the tolerance of transdermal nitrate therapy.
Giancarlo Longobardi; Nicola Ferrara; Pasquale Abete; Dario Leosco; Giuseppe Furgi; Antonio Nicolino; Dino Franco Vitale; Franco Rengo
Related Documents :
11048658 - The myocardial heat shock response following sodium salicylate treatment.
11696828 - Combined dipyridamole and dobutamine echocardiography in myocardial hibernation: compar...
12736478 - Observation of the ischemic cascade in humans using contrast echocardiography during do...
2217008 - Dipyridamole echocardiography: the bedside stress test for coronary artery disease.
12003798 - Role of delta-opioid receptor agonists on infarct size reduction in swine.
8608458 - Diastolic dysfunction.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy     Volume:  16     ISSN:  0920-3206     ISO Abbreviation:  Cardiovasc Drugs Ther     Publication Date:  2002 Dec 
Date Detail:
Created Date:  2003-05-26     Completed Date:  2003-07-11     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8712220     Medline TA:  Cardiovasc Drugs Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  535-42     Citation Subset:  IM    
Fondazione Salvatore Maugeri, IRCCS, Rehabilitation Institute of Telese Terme, Division of Cardiology, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Cutaneous
Coronary Artery Disease / diagnosis*,  drug therapy*
Cross-Over Studies
Dipyridamole / diagnostic use*
Double-Blind Method
Echocardiography, Stress
Heart Ventricles / drug effects,  ultrasonography
Hemodynamics / drug effects,  physiology
Infusions, Intravenous
Middle Aged
Myocardial Ischemia / diagnosis*,  drug therapy*
Nitroglycerin / administration & dosage*
Prospective Studies
Treatment Outcome
Vasodilator Agents / administration & dosage*
Reg. No./Substance:
0/Vasodilator Agents; 55-63-0/Nitroglycerin; 58-32-2/Dipyridamole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Efficacy of percutaneous intramyocardial injections using a nonfluoroscopic 3-D mapping based cathet...
Next Document:  Clinical profile of eprosartan.